Company intelligence / Profile preview

SyntheX

San Francisco, California, United States
Ownership
Private
Employees
~50
Development stage
Preclinical
01

Overview

SyntheX has developed a proprietary cell-based synthetic biology drug discovery platform called ToRFLEx. This enables the identification of compounds that modulate challenging or "undruggable" protein targets by disrupting protein-protein interactions or inducing targeted protein degradation. The company's primary therapeutic area is oncology, with a pipeline focused on novel mechanisms such as synthetic lethality and oncogene addiction. Several programs are in preclinical or discovery stages; some earlier candidates have been discontinued.

Therapeutic areas
OncologyRare Diseases
Modalities
Molecular gluesSmall moleculesPeptides and macrocycles (cell-based)
Industry
Biotech
02

Drug pipeline

7 assets

STX-100 (SyntheX)

Preclinical

6 more assets in the full pipeline.

Request access →
03

Partnerships

Beyond the preview

Go deeper on SyntheX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SyntheX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call